Skip to main content
logo
Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
2.550
+0.030 (1.19%)
Oct 19, 2026, 4:10 PM AEST

Mayne Pharma Group Revenue

In the fiscal year ending June 30, 2026, Mayne Pharma Group had annual revenue of 383.68M AUD, down -5.98%. Mayne Pharma Group had revenue of 171.61M in the half year ending June 30, 2026, a decrease of -14.40%. That makes Mayne Pharma Group the 15,335th largest company in the world by revenue and 260th in Australia.

Revenue
383.68M
Revenue Growth
-5.98%
P/S Ratio
0.54
Revenue / Employee
1.06M
Employees
363
Market Cap
208.82M

Revenue Chart

Chart

Revenue by Segment

By Segment

Chart
  • Women's Health 174.27M 45.4%
  • Dermatology 138.70M 36.1%
  • International 70.71M 18.4%

By Geography

Chart
  • United States 318.40M 83.0%
  • Australia and New Zealand 38.25M 10.0%
  • Canada 15.42M 4.0%
  • Europe and Other 6.61M 1.7%
  • Asia 4.99M 1.3%
Fiscal year ended Jun 30, 2026 See the full Mayne Pharma Group breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2026383.68M-24.42M-5.98%
Jun 30, 2025408.10M19.70M5.07%
Jun 30, 2024388.40M204.81M111.56%
Jun 30, 2023183.59M26.44M16.82%
Jun 30, 2022157.15M-243.63M-60.79%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CSL Limited22.83B
Ramsay Health Care18.65B
Sigma Healthcare10.83B
Paragon Care3.68B
Healius1.37B
Monash IVF Group269.46M
Pro Medicus261.69M
Aroa Biosurgery86.47M
Revenue Rankings

Mayne Pharma Group News

More News